Cargando…
The CD28-B7 Family in Anti-Tumor Immunity: Emerging Concepts in Cancer Immunotherapy
The interactions between B7 molecules and CD28-family receptors are crucial in the regulation of adaptive cellular immunity. In cancer, the aberrant expression of co-inhibitory B7 molecules has been attributed to reduced anti-tumor immunity and cancer immune evasion, prompting the development of can...
Autores principales: | Leung, Joanne, Suh, Woong-Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4275384/ https://www.ncbi.nlm.nih.gov/pubmed/25550693 http://dx.doi.org/10.4110/in.2014.14.6.265 |
Ejemplares similares
-
Soluble B7-CD28 Family Inhibitory Immune Checkpoint Proteins and Anti-Cancer Immunotherapy
por: Khan, Muhammad, et al.
Publicado: (2021) -
Emerging concepts regarding pro- and anti tumor properties of B cells in tumor immunity
por: Qin, You, et al.
Publicado: (2022) -
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
por: Wang, Yuchen, et al.
Publicado: (2022) -
Upregulation of the B7/CD28 family member B7-H3 in bladder cancer
por: WU, DEYAO, et al.
Publicado: (2015) -
New emerging targets in cancer immunotherapy: CD27 (TNFRSF7)
por: Starzer, Angelika M., et al.
Publicado: (2020)